MNST
65
5
LRCX
43
-2
HRB
54
2
ROST
54
9
CFG
52
-2
URBN
55
12
EQR
44
7
GS
52
-7
BEN
33
-5
NWL
54
-2
CCI
28
3
XRAY
34
11
FDX
30
-9
IR
57
2
MMM
28
-2
MHK
43
4
GOOG
55
-4
COF
57
-2
VFC
65
2
KHC
22
-3
MNST
65
5
LRCX
43
-2
HRB
54
2
ROST
54
9
CFG
52
-2
URBN
55
12
EQR
44
7
GS
52
-7
BEN
33
-5
NWL
54
-2
CCI
28
3
XRAY
34
11
FDX
30
-9
IR
57
2
MMM
28
-2
MHK
43
4
GOOG
55
-4
COF
57
-2
VFC
65
2
KHC
22
-3
Financhill
Back

Armata Pharmaceuticals 10K Form

Buy
69

ARMP
Armata Pharmaceuticals

Last Price:
2.36
Seasonality Move:
17.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARMP News And Ratings

See the #1 stock for the next 7 days that we like better than ARMP

ARMP Financial Statistics

Sales & Book Value

Annual Sales: $820K
Cash Flow: $-11.54M
Price / Cash Flow: 0
Annual Sales: $-1.28
Price / Book: 0

Profitability

EPS (TTM): -2.35000
Net Income (TTM): $-67.04M
Gross Margin: $410K
Return on Equity: 0%
Return on Assets: 0%

Armata Pharmaceuticals Earnings Forecast

Key Armata Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ARMP is 100.24%.
  • The Selling, General & Administrative Expenses for ARMP have been equal to 971.46% of Gross Profit Margin.
  • The Interest Expense is -3.80% of Operating Income.
  • Per Share Earnings over the last 28 years have been positive in 11 years.

Armata Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARMP
CUSIP: 04216R
Website: armatapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARMP Technical Analysis vs Fundamental Analysis

Buy
69
Armata Pharmaceuticals (ARMP) is a Buy

Is Armata Pharmaceuticals a Buy or a Sell?